CTS Corp

CTS Corp

IndustrialsElectronic & Electrical Equipment
  • Price (USD)21.31
  • Today's Change0.06 / 0.28%
  • Shares traded202.13k
  • 1 Year change-33.94%
  • Beta0.7849
Data delayed at least 15 minutes, as of Sep 24 2020 21:10 BST.
More ▼

Profile data is unavailable for this security.

About the company

CTS Corporation is a manufacturer of sensors, electronic components and actuators. The Company designs, manufactures and sells a line of sensors, electronic components and actuators primarily to original equipment manufacturers (OEMs) for the transportation, industrial, medical, information technology, defense and aerospace, and communications markets. It operates manufacturing facilities in North America, Asia and Europe. Its products perform specific electronic functions for a given product family and are intended for use in customer assemblies. The Company's products consist principally of sensors and actuators used in passenger or commercial vehicles; electronic components used in communications infrastructure, information technology and other high-speed applications; switches and potentiometers supplied to multiple markets, and fabricated piezoelectric materials and substrates used primarily in medical, industrial, defense and aerospace, and information technology markets.

  • Revenue in USD (TTM)417.96m
  • Net income in USD21.45m
  • Incorporated1929
  • Employees3.57k
  • Location
    CTS Corp4925 Indiana AveLISLE 60532-1611United StatesUSA
  • Phone+1 (630) 577-8800
  • Fax+1 (574) 294-5178
  • Websitehttps://www.ctscorp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Luna Innovations Incorporated73.62m4.95m182.64m289.0038.402.6225.562.480.15440.10722.322.270.84913.444.02275,722.205.84-0.97737.00-1.2751.0042.536.88-1.223.35--0.0007--64.3127.10415.76--16.20--
Transcat, Inc.169.61m7.15m217.14m772.0030.633.2215.451.280.95620.956222.549.101.438.486.22219,699.506.
MTS Systems Corporation837.61m13.45m368.76m3.50k27.610.75216.370.44030.69290.692943.3125.430.6253.194.08239,318.001.003.621.234.6834.8037.921.614.801.261.620.549457.2014.719.6015.02-0.11218.780.00
Fluidigm Corporation112.61m-54.57m509.56m566.00--3.84--4.52-0.7777-0.77771.611.860.39782.957.70198,959.40-19.28-19.56-22.25-21.7656.5855.22-48.46-56.901.55-17.910.2893--3.790.1348-9.79---19.32--
Diebold Nixdorf Inc4.03bn-274.80m546.83m22.00k------0.1356-3.56-3.5652.26-,254.50-7.04-5.49-11.81-9.6825.4122.96-6.83-5.710.90450.40791.39---3.7110.0236.63---6.52--
IMPINJ Inc155.86m-33.62m571.84m272.00--4.90--3.67-1.50-1.506.985.100.83922.188.49573,022.10-18.10-11.89-20.58-14.1547.5250.30-21.57-12.905.65-8.430.3118--24.6319.1134.75--19.02--
Accelerate Diagnostics Inc10.21m-82.31m586.09m275.00------57.42-1.50-1.500.186-0.65760.07470.654.5337,120.00-60.20-54.88-64.35-57.5445.81---806.31-1,783.959.27-5.261.36--63.97137.904.55---29.78--
CTS Corporation417.96m21.45m687.62m3.57k32.611.7214.541.650.65350.653512.7312.420.67196.475.78117,076.503.455.924.017.2632.3534.
Quanterix Corp59.72m-44.74m992.25m248.00--8.07--16.62-1.61-1.612.153.910.43862.996.40240,802.40-32.86---37.85--43.41---74.92--5.32--0.0643--50.76---29.36------
FARO Technologies, Inc.334.74m-79.65m996.51m1.82k--3.23--2.98-4.55-4.5519.0717.360.68542.675.46184,123.20-16.31-1.35-20.56-1.6349.9353.85-23.79-1.702.40-152.430.0018---5.422.23-1,360.59---15.11--
Mesa Laboratories, Inc.121.34m-2.22m1.23bn460.00--3.2198.3210.12-0.5162-0.516227.3774.900.32965.297.86263,782.60-0.60373.06-0.64013.4456.6757.56-1.835.6912.541.160.270343.4514.1110.53-82.08-32.44-11.930.637
OSI Systems, Inc.1.17bn75.25m1.40bn6.76k19.112.4311.,542.805.943.438.264.9836.0735.266.453.831.145.930.36370.00-1.364.0016.142.929.42--
Data as of Sep 24 2020. Currency figures normalised to CTS Corp's reporting currency: US Dollar USD

Institutional shareholders

64.44%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 20204.59m14.23%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 20203.40m10.54%
Wellington Management Co. LLPas of 31 Jul 20203.26m10.11%
The Vanguard Group, Inc.as of 30 Jun 20202.04m6.31%
GAMCO Asset Management, Inc.as of 30 Jun 20201.80m5.58%
Dimensional Fund Advisors LPas of 30 Jun 20201.71m5.31%
Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 20201.25m3.87%
SSgA Funds Management, Inc.as of 30 Jun 20201.05m3.26%
Goldman Sachs Asset Management LPas of 30 Jun 2020947.68k2.94%
Victory Capital Management, Inc. (Investment Management)as of 30 Jun 2020740.97k2.30%
More ▼
Data from 30 Jun 2020 - 30 Jun 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.